浙江交科(002061) - 2020 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2020 was ¥4,767,980,472.14, a decrease of 3.09% compared to ¥4,919,818,852.89 in the same period last year[9]. - Net profit attributable to shareholders was ¥9,900,952.70, down 80.61% from ¥51,063,818.95 year-on-year[9]. - The net profit after deducting non-recurring gains and losses was ¥2,058,221.41, a decline of 95.70% compared to ¥47,899,406.35 in the previous year[9]. - Basic and diluted earnings per share were both ¥0.01, a decrease of 75.00% from ¥0.04 year-on-year[9]. - The total comprehensive income decreased by 104.62% to -¥2,253,243.22 from ¥48,814,160.29 year-on-year[26]. - The operating profit dropped by 72.95% to ¥28,024,646.96, primarily due to the narrowing of the price gap between chemical products and raw materials, leading to a decrease in product gross margin[26]. - The total profit for the current period is ¥28,165,566.54, down from ¥104,308,347.56 in the previous period, reflecting a decrease of approximately 73%[70]. - The company's operating profit for the current period is ¥28,024,646.96, compared to ¥103,591,123.52 in the previous period, showing a decline of about 73%[70]. Cash Flow - The net cash flow from operating activities was -¥216,244,247.94, an improvement of 61.25% from -¥558,068,457.87 in the same period last year[9]. - The cash flow from operating activities showed a net outflow of -¥216,244,247.94, a 61.25% improvement compared to -¥558,068,457.87 in the previous year[26]. - Total cash inflow from operating activities amounted to 9,856,471,314.27, compared to 8,020,725,746.67 in the prior period, reflecting a year-over-year increase of approximately 22.9%[82]. - Cash outflow from operating activities totaled 10,072,715,562.21, which is an increase from 8,578,794,204.54, representing a rise of about 17.4%[82]. - The net cash flow from investment activities was -177,116,669.80, worsening from -22,876,491.64 in the previous period[85]. - Cash inflow from financing activities reached 956,500,000.00, up from 719,500,000.00, indicating a growth of approximately 32.9%[85]. - The net cash flow from financing activities was -701,085,714.76, compared to -18,726,552.32 in the prior period, indicating a significant decline[85]. Assets and Liabilities - Total assets at the end of the reporting period were ¥27,638,252,965.31, down 18.23% from ¥33,798,055,234.94 at the end of the previous year[9]. - The company's total assets decreased to approximately 27.64 billion RMB from 33.80 billion RMB, a reduction of about 18.19%[49]. - Total liabilities decreased to approximately 19.12 billion RMB from 25.28 billion RMB, a decline of about 24.25%[52]. - The company's long-term equity investments increased to approximately 546 million RMB from 489 million RMB, an increase of about 11.59%[49]. - The company reported a decrease in short-term loans to approximately 3.66 billion RMB from 3.68 billion RMB, a reduction of about 0.36%[51]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 34,900, with the largest shareholder holding 57.15% of the shares[14]. - The company's net assets attributable to shareholders were ¥7,734,606,093.05, a slight increase of 0.13% from ¥7,724,705,140.34 at the end of the previous year[9]. - The total equity attributable to shareholders increased to CNY 6,140,423,281.06 from CNY 6,108,617,624.25, reflecting a strengthening of the company's capital base[61]. Investment and Expenses - The company reported a significant increase in investment payments, which rose by 163.90% to ¥81,518,500.00, mainly due to investments in associated enterprises[26]. - Research and development expenses were CNY 44,518,633.53, down from CNY 52,943,703.52, suggesting a potential shift in investment strategy[64]. - The company incurred asset impairment losses of ¥19,675,889.97 in the current period, compared to ¥2,208,783.28 in the previous period[70]. Other Financial Metrics - The company reported non-recurring gains and losses totaling ¥7,842,731.29 for the period[9]. - The company experienced a 191.76% increase in other income, reaching ¥8,446,328.70, mainly due to government subsidies received during the period[26]. - The company maintained a strong cash position with cash and cash equivalents of CNY 439,445,082.44, up from CNY 423,067,944.62, indicating good liquidity management[56]. - The company has no derivative investments or violations regarding external guarantees during the reporting period[39][40]. - There were no non-operating fund occupations by controlling shareholders or related parties during the reporting period[41].